FDA Drug Application (010533) for PBZ-SR by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number010533
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage100MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePBZ-SR
Active IngredientTRIPELENNAMINE HYDROCHLORIDE



Back to FDA Applications sponsored by NOVARTIS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.